Approval · Notice of Compliance 12138 · 2011
NEXT CHOICE: Notice of Compliance 12138
Issued March 9, 2011
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 12138
- Date
- March 9, 2011
- Company
- Cobalt Pharmaceuticals IncorporatedToronto, Ontario, Canada
- Product type
- Nonprescription Pharmaceutical
- Submission
- Abbreviated New Drug Submission (ANDS)
- Submission class
- Other
- Therapeutic class
- Emergency contraception
- Canadian reference product
- PLAN B
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| NEXT CHOICE | 02364905 | Cancelled Post Market |
Medicinal ingredients
- LEVONORGESTREL 0.75 MG per TAB